P, L., R, M., N, A., S, H., JF, F., N, A., . . . V, L. (2022). 4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives. Pharmaceuticals (Basel, Switzerland), 15(7), . https://doi.org/10.3390/ph15070820
Chicago Style (17th ed.) CitationP, Lagardère, et al. "4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives." Pharmaceuticals (Basel, Switzerland) 15, no. 7 (2022). https://doi.org/10.3390/ph15070820.
MLA (9th ed.) CitationP, Lagardère, et al. "4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives." Pharmaceuticals (Basel, Switzerland), vol. 15, no. 7, 2022, https://doi.org/10.3390/ph15070820.
Warning: These citations may not always be 100% accurate.